South Africa’s data rollout of its pre-exposure prophylaxis shows that there is a relatively slow, but increasing, uptake. However, more needs to be done to target young women.
A clinical trial currently underway in France could confirm that that HIV treatment can be safely reduced to just four days a week, while maintaining the same efficacy.
To get an effective vaccine for HIV/AIDS, scientists need to understand exactly how the virus works and immune system responds to it. African scientists have come one step closer.
HIV remains a synonym for death in Kinshasa and many leave testing and treatment until it’s too late. It’s not common knowledge that an infected person can live a normal and healthy life.
Activists supporting the decriminalisation of sex work at the 21st International AIDS Conference in Durban, South Africa.
International AIDS Society/Abhi Indrarajan
South Africa has launched a plan to tackle HIV, TB and sexually transmitted infections – but much depends on its implementation over the next five years.
People with a certain gene have an adverse reaction to the antiretroviral efavirenz.
Shutterstock
South Africa and Zimbabwe have made significant strides to roll out antiretrovirals. But the regional expansion of treatment programmes still needs work.
A photomicrograph of the Cryptococcus fungus.
www.einstein.yu.edu
More than 250 000 patients at highest risk for cryptococcal meningitis but no symptoms will be screened in South Africa annually to reduce the number of deaths.
Martin Mbonye, MRC/UVRI Uganda Research Unit on AIDS; Janet Seeley, London School of Hygiene & Tropical Medicine e Monica Kuteesa, MRC/UVRI Uganda Research Unit on AIDS
Medical circumcision in settings where there are high rates of HIV will only be successful if these interventions take into account local beliefs about circumcision.
Many people with moderate to severe chronic pain find it difficult to move around. By contrast, HIV-positive people who had chronic pain are still active.
Testing and treatment is important in tackling HIV. But stigma and access need to be addressed too.
Shutterstock
Taking antiretrovirals is key to reducing HIV infection rates, but the challenge lies in making sure people who know they are infected actually take the drugs.
Indian Prime Minister Narendra Modi and Kenyan President Uhuru Kenyatta address a news conference at State House in Nairobi.
Reuters/Thomas Mukoya
Narendra Modi’s first trip to Africa has widely been heralded as a success, but his brand of diplomacy has left the most pressing issues for the continent unaddressed.
South African HIV rights group, the Treatment Action Campaign, marching through Durban, calling for antiretroviral access for all.
International AIDS Society/Rogan Ward
Current epidemiological and financial trends suggest there’s a major risk of a substantial shortfall in the funds required to sustain life-saving antiretroviral programmes.
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity